Sergio Traversa, CEO: Relmada Therapeutics RLMD Buy · Filed 24/01/31

Trade details

Type: Insider buy
Amount: $159,896.1
Shares · price: 40,999 sh · $3.90 a share
Held after: 216,564 sh
Stock: Relmada Therapeutics RLMD
Person: Sergio TraversaCEO
Trade date: 24/01/30
Filed: 24/01/31
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +23.4%

Relmada Therapeutics trades, last 26 weeks

What else happened in Relmada Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/31~24/02/29

Sergio Traversa's recent trades

Sergio TraversaCEO
BuyRelmada Therapeutics
Buy
Relmada Therapeutics
RLMD
$113.3K
27,500 sh
$113.3K
Filed 25/12/16
Traded 25/12/15
Sergio TraversaCEO
BuyRelmada Therapeutics
Buy
Relmada Therapeutics
RLMD
$599.5K
272,500 sh
$599.5K
Filed 25/11/06
Traded 25/11/05
Sergio TraversaCEO
BuyRelmada Therapeutics
Buy
Relmada Therapeutics
RLMD
$86.7K
129,455 sh
$86.7K
Filed 25/08/28
Traded 25/08/27
Sergio TraversaCEO
BuyRelmada Therapeutics
Buy
Relmada Therapeutics
RLMD
$49.9K
80,545 sh
$49.9K
Filed 25/08/28
Traded 25/08/26
Sergio TraversaCEO
BuyRelmada Therapeutics
Buy
Relmada Therapeutics
RLMD
$41.4K
55,976 sh
$41.4K
Filed 25/08/28
Traded 25/08/28

Sergio Traversa, CEO — bought $159.9K of Relmada Therapeutics RLMD · 40,999 sh @ $3.90 | Whalegun